Literature DB >> 11583910

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.

V Fuster, L E Rydén, R W Asinger, D S Cannom, H J Crijns, R L Frye, J L Halperin, G N Kay, W W Klein, S Lévy, R L McNamara, E N Prystowsky, L S Wann, D G Wyse, R J Gibbons, E M Antman, J S Alpert, D P Faxon, V Fuster, G Gregoratos, L F Hiratzka, A K Jacobs, R O Russell, S C Smith, W W Klein, A Alonso-Garcia, C Blomström-Lundqvist, G De Backer, M Flather, J Hradec, A Oto, A Parkhomenko, S Silber, A Torbicki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11583910     DOI： 10.1016/s0735-1097(01)01587-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  122 in total

1.  Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations.

Authors:  Holger J Schünemann; Dana Best; Gunn Vist; Andrew D Oxman
Journal:  CMAJ       Date:  2003-09-30       Impact factor: 8.262

Review 2.  A review of clinical trials assessing the efficacy and safety of newer antiarrhythmic drugs in atrial fibrillation.

Authors:  Gerald V Naccarelli; Deborah L Wolbrette; Luna Bhatta; Mazhar Khan; John Hynes; Soraya Samii; Jerry Luck
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

Review 3.  Why is warfarin underutilized in patients with atrial fibrillation?

Authors:  Greg C Flaker; John Schutz
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

4.  A review of current surgical treatment of patients with atrial fibrillation.

Authors:  Zachary J Edgerton; James R Edgerton
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-07

Review 5.  [Oral anticoagulation and risk of bleeding in elderly patients - the aspect of polypharmacy].

Authors:  Regina E Roller; Bernhard Iglseder; Peter Dovjak; Monika Lechleitner; Ulrike Sommeregger; Ursula Benvenuti-Falger; Ronald Otto; Birgit Böhmdorfer; Markus Gosch
Journal:  Wien Med Wochenschr       Date:  2010-06

Review 6.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  Oral anticoagulation in patients aged 75 years or older with chronic non-valvar atrial fibrillation: effectiveness and safety in daily clinical practice.

Authors:  M Ruiz Ortiz; E Romo Peñas; M F Franco Zapata; D Mesa Rubio; M Anguita Sánchez; A López Granados; J M Arizón del Prado; F Vallés Belsué
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

Review 8.  Ablation of atrial fibrillation.

Authors:  Eduardo B Saad; Nassir F Marrouche; Andrea Natale
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

Review 9.  Atrial fibrillation: how to approach rate control.

Authors:  Lynda E Rosenfeld
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

10.  Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation.

Authors:  Meng Han; Miao Zhao; Chen Cheng; Yuan Huang; Shengna Han; Wenjuan Li; Xin Tu; Xuan Luo; Xiaoling Yu; Yinan Liu; Qiuyun Chen; Xiang Ren; Qing Kenneth Wang; Tie Ke
Journal:  Hum Mutat       Date:  2018-12-08       Impact factor: 4.878
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.